DISCUSSIONS
ON SAFETY CONCERNS |
|
Beta-blockers
for ophthalmic use Risk of systemic adverse reactions |
|
GEMCITABINE
ACTAVIS Risk of adverse reactions due to increased alcohol
concentration after reconstitution error |
|
Hydrochlorothiazide
Use during breast-feeding |
|
Testosterone
10% for topical use Risk of virilisation in children after
exposure through interpersonal skin contact |
GUIDELINES
AND GENERAL MATTERS |
|
Meetings
of the International Conference on Harmonisation of Technical Requirements
for Registration of Pharmaceuticals for Human Use (ICH) in June 2011 |
|
Guide on the interpretation of spontaneous case reports of suspected
adverse reactions to medicines |
|
Study
of influential stakeholders expectations and attitudes regarding
benefit-risk communication by the European Medicines Agency |
|
Driving
under the Influence of Drugs, Alcohol and Medicines - The Integrated
Project DRUID under the European Commissions 6th Framework Programme |